Targeting oxidative stress in embryonal rhabdomyosarcoma
Xiang Chen1, Elizabeth Stewart2, Anang A Shelat3
1Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Cancer Cell
|December 17, 2013
Summary
Rhabdomyosarcoma, a soft-tissue cancer, presents distinct subtypes with varying genetic profiles. Oxidative stress emerges as a key therapeutic target for embryonal rhabdomyosarcoma (ERMS).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Rhabdomyosarcoma is a soft-tissue sarcoma originating from developing skeletal muscle.
- It comprises two main subtypes: embryonal rhabdomyosarcoma (ERMS) and alveolar rhabdomyosarcoma (ARMS), each with unique clinical, molecular, and genetic characteristics.
Purpose of the Study:
- To investigate the genomic landscape of ERMS and ARMS.
- To identify potential therapeutic targets for ERMS by developing and characterizing orthotopic xenografts.
Main Methods:
- Genomic analysis was performed on ERMS and ARMS tumors.
- Orthotopic xenografts were established from ERMS tumors.
- Primary cultures from xenografts underwent high-throughput screening.
Main Results:
- ERMS tumors exhibit more structural and copy number variations compared to ARMS.
- Mutations in the RAS/NF1 pathway are linked to intermediate- and high-risk ERMS.
- High-throughput screening identified oxidative stress as a relevant pathway for ERMS therapeutics.
Conclusions:
- Distinct genetic profiles differentiate ERMS and ARMS.
- Oxidative stress represents a promising therapeutic avenue for embryonal rhabdomyosarcoma.
